Price $111.90 |
Market Cap
23.1B
|
Sector Health Care |
Div. Growth
1.00%
|
P/E
101.1
|
P/B
-
|
P/S
0.12
|
Dividend %
2.00%
|
P/CF
-
|
P/FCF
14.0
|
Op. Cash Flow
2.84M
|
FCF
7.1
|
Op. Margin
0.40%
|
Net Margin
0.10%
|
ROE
-11.50%
|
ROI
19.00%
|
ROA
0.60%
|
EPS Growth
129.30%
|
Current Ratio
1.0
|
Debt/Equity
-
|
Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
---|---|---|---|---|---|
Cidara Therapeutics Inc (CDTX) | $0.92 | - | - | 78M | Strong Buy |
Interpace Biosciences Inc (IDXG) | $1.50 | - | - | 4.1M | Strong Buy |
Jazz Pharmaceuticals PLC (JAZZ) | $120.42 | - | - | 8.13B | Strong Buy |
Bimi International Medical Inc (BIMI) | $1.68 | - | - | 6.4M | Strong Buy |
Journey Medical Corp (DERM) | $3.68 | - | - | 43.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More